6 results
424B5
Teva Pharmaceutical Finance Netherlands II B.V.
4 Nov 21
Prospectus supplement for primary offering
4:41pm
of its accuracy. Teva’s efforts in achieving the Sustainability Performance Targets may further become controversial or be criticized by activist
424B3
Teva Pharmaceutical Finance Netherlands II B.V.
27 Oct 21
Prospectus supplement
8:51am
by activist groups or other stakeholders. In addition, through the increased use of social media, individuals and non-governmental organizations have
424B5
Teva Pharmaceutical Finance Netherlands II B.V.
18 Jul 16
Prospectus supplement for primary offering
12:00am
of Teva and activist investors, as well as to customary standstill limitations. Allergan agreed to vote its Teva shares, subject to certain exceptions
6-K
TEVA
Teva- Pharmaceutical Industries Ltd.
13 Jul 16
Current report (foreign)
12:00am
. In addition, Allergan will be prohibited from transfers of the Teva shares during a 12-month lockup period or to certain competitors of Teva and activist
- Prev
- 1
- Next